These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 12555163

  • 1. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?
    Pitt B.
    J Card Fail; 2002 Dec; 8(6 Suppl):S491-3. PubMed ID: 12555163
    [Abstract] [Full Text] [Related]

  • 2. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Iraqi W, Rossignol P, Angioi M, Fay R, Nuée J, Ketelslegers JM, Vincent J, Pitt B, Zannad F.
    Circulation; 2009 May 12; 119(18):2471-9. PubMed ID: 19398668
    [Abstract] [Full Text] [Related]

  • 3. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies.
    Pitt B.
    Mol Cell Endocrinol; 2004 Mar 31; 217(1-2):53-8. PubMed ID: 15134801
    [Abstract] [Full Text] [Related]

  • 4. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
    Udelson JE, Feldman AM, Greenberg B, Pitt B, Mukherjee R, Solomon HA, Konstam MA.
    Circ Heart Fail; 2010 May 31; 3(3):347-53. PubMed ID: 20299607
    [Abstract] [Full Text] [Related]

  • 5. Blocking aldosterone in heart failure.
    Shafiq MM, Miller AB.
    Ther Adv Cardiovasc Dis; 2009 Oct 31; 3(5):379-85. PubMed ID: 19661156
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Review article: eplerenone: an underused medication?
    Abuannadi M, O'Keefe JH.
    J Cardiovasc Pharmacol Ther; 2010 Dec 31; 15(4):318-25. PubMed ID: 20876342
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr 31; 15(82):46-9. PubMed ID: 16604728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Optimizing care of heart failure after acute MI with an aldosterone receptor antagonist.
    Verma A, Solomon SD.
    Curr Heart Fail Rep; 2007 Dec 31; 4(4):183-9. PubMed ID: 18221614
    [Abstract] [Full Text] [Related]

  • 12. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D, Galuppo P, Schmidt I, Ertl G, Bauersachs J.
    Cardiovasc Res; 2005 Jul 01; 67(1):97-105. PubMed ID: 15949473
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
    Wahed MI, Watanabe K, Ma M, Yamaguchi K, Takahashi T, Tachikawa H, Kodama M, Aizawa Y.
    Pharmacology; 2005 Feb 01; 73(2):81-8. PubMed ID: 15467302
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
    Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R, EPHESUS Investigators.
    Circulation; 2008 Oct 14; 118(16):1643-50. PubMed ID: 18824643
    [Abstract] [Full Text] [Related]

  • 17. Aldosterone antagonism and congestive heart failure: a new look at an old therapy.
    Thohan V, Torre-Amione G, Koerner MM.
    Curr Opin Cardiol; 2004 Jul 14; 19(4):301-8. PubMed ID: 15218387
    [Abstract] [Full Text] [Related]

  • 18. [New evidences on the use of aldosterone receptor antagonists in left ventricular dysfunction: from myocardial infarction to heart failure].
    Greco C, Castelli G, Crea F, Gavazzi A, Gensini GF, Scherillo M, Sinagra G.
    G Ital Cardiol (Rome); 2012 Dec 14; 13(12):809-16. PubMed ID: 23196683
    [Abstract] [Full Text] [Related]

  • 19. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG, Schencking M, Scheer C, Rupp H.
    Praxis (Bern 1994); 1997 Apr 02; 86(14):566-74. PubMed ID: 9198851
    [Abstract] [Full Text] [Related]

  • 20. Aldosterone blockade in patients with systolic left ventricular dysfunction.
    Pitt B.
    Circulation; 2003 Oct 14; 108(15):1790-4. PubMed ID: 14557343
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.